Eton Pharmaceuticals, Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
21925 W. FIELD PARKWAY, DEER PARK, IL, 60010-7278
Mailing Address
21925 W. FIELD PARKWAY, DEER PARK, IL, 60010-7278
Phone
(847) 787-7361
Fiscal Year End
1231
EIN
371858472
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 10-K Annual financial report | March 19, 2026 | View on SEC |
| 8-K Current report of material events | March 19, 2026 | View on SEC |
| 8-K Current report of material events | March 2, 2026 | View on SEC |
| 8-K Current report of material events | February 25, 2026 | View on SEC |
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
| 8-K Current report of material events | February 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 14, 2026 | View on SEC |
| 4 Insider stock transaction report | January 14, 2026 | View on SEC |
| 4 Insider stock transaction report | January 14, 2026 | View on SEC |
Annual Reports
10-K
March 19, 2026
- Acquisition of Increlex® (Dec 2024) provides immediate, steady income and expands market reach for 2025.
- Successful launch of multiple specialized products (PKU GOLIKE, Selenix DS200, Galzin) in 2024.
Material Events
8-K
Acquisition
March 2, 2026
High Impact
- Immediate revenue and profit growth from an established, FDA-approved product.
- Strategic expansion into specialized pharmaceutical markets with an Orphan Drug designated product.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.